Differential diagnosis of solitary pulmonary nodules using 99mTc-3P 4-RGD 2 scintigraphy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 12, 2011, Pages 2145-2152

  Ma, Qingjie ^a   Ji, Bin ^a   Jia, Bing ^b   Gao, Shi ^a   Ji, Tiefeng ^a   Wang, Xueju ^a   Han, Zhenguo ^a   Zhao, Guoqing ^a  

^a JILIN UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

99mTc 3P 4 RGD 2; Integrin 3; Scintigraphy; Solitary pulmonary nodule

Indexed keywords

ALPHA5 INTEGRIN; ARGINYLGLYCYLASPARTYLSERINE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG TUMOR LEVEL; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NODULE; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR SCINTISCANNING; TUMOR VOLUME;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84856209326     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1901-2     Document Type: Article

References (28)

1. Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003;138(9):724-35. (Pubitemid 38139236)
2. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004;9(6):633-43. doi:10.1634/theoncologist.9-6-633. (Pubitemid 39546404)
3. Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer. Semin Nucl Med 2004;34(2):134-53. (Pubitemid 38375468)
4. Jeong SY, Lee KS, Shin KM, Bae YA, Kim BT, Choe BK, et al. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules. Lung Cancer 2008;61(2):186-94. doi:10.1016/j.lungcan. 2007.12.021.
5. Rebollo AC, Jiménez-Hoyuela JM, Martínez del Valle MD Martinez, Fernández Aguirre C, Soria C, Velasco JL. [Lung scintigraphy with technetium 99m depreotide in the assessment of solitary pulmonary nodules]. Arch Bronconeumol 2004;40(11):534-6. (Pubitemid 39578199)
6. Plachcińska A, Mikołajczak R, Maecke HR, Michalski A, Rzeszutek K, Kozak J, et al. 99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004;31(7):1005-10. doi:10.1007/s00259-004-1511-3. (Pubitemid 38915657)
7. Spanu A, Schillaci O, Pirina P, Arru A, Madeddu G, Chessa F, et al. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation. Oncol Rep 2006;16(4):763-9.
8. Niu G, Chen X. Why integrin as a primary target for imaging and therapy. Theranostics 2011;1:30-47.
9. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, et al. Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia 2005;7(3):271-9. doi:10.1593/neo.04538. (Pubitemid 40411639)
10. Jia B, Liu Z, Zhu Z, Shi J, Jin X, Zhao H, et al. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kitformulated integrin alpha (v) beta (3)-selective radiotracer (99m) Tc-3PRGD (2) in non-human primates. Mol Imaging Biol 2011;13(4):730-6. doi:10.1007/s11307-010-0385-y.
11. Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, et al. Improving tumor-targeting capability and pharmacokinetics of (99m) Tclabeled cyclic RGD dimers with PEG (4) linkers. Mol Pharm 2009;6(1):231-45. doi:10.1021/mp800150r.
12. Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, et al. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. J Nucl Med 2006;47(1):113-21.
13. Liu Z, Jia B, Shi J, Jin X, Zhao H, Li F et al. Tumor uptake of the RGD dimeric probe (99m) Tc-G (3)-2P (4)-RGD2 is correlated with integrin alpha (v) beta (3) expressed on both tumor cells and neovasculature. Bioconjug Chem 2010. doi:10.1021/bc900547d.
14. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, Grosu AL, et al. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha (v) beta3 expression in man. Clin Cancer Res 2006;12(13):3942-9. doi:10.1158/1078-0432. ccr-06-0266. (Pubitemid 44078079)
15. Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud TV, Fangberget A, et al. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692. J Nucl Med 2006;47(9):1434-9. (Pubitemid 47544928)
16. Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, et al. Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med 2008;49(6):879-86. doi:10.2967/jnumed.107.049452. (Pubitemid 351793427)
17. Gottschalk KE, Kessler H. The structures of integrins and integrinligand complexes: implications for drug design and signal transduction. Angew Chem Int Ed Engl 2002;41(20):3767-74. doi:10.1002/1521-3773(20021018) 41:20<3767::aid-anie3767>3.0.co;2-t. (Pubitemid 35277998)
18. Liu S. Radiolabeled cyclic RGD peptides as integrin alpha (v) beta (3) - targeted radiotracers: maximizing binding affinity via bivalency. Bioconjug Chem 2009;20(12):2199-213. doi:10.1021/bc900167c.
19. Dijkgraaf I, Boerman OC. Molecular imaging of angiogenesis with SPECT. Eur J Nucl Med Mol Imaging 2010;37 Suppl 1:S104-13. doi:10.1007/s00259-010-1499- 9.
20. Viggiano RW, Swensen SJ, Rosenow 3rd EC. Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1992;13(1):83-95.
21. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285(7):914-24. (Pubitemid 32171553)
22. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007;48(2):214-20. (Pubitemid 47555346)
23. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41(8):1369-79. (Pubitemid 30643379)
24. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18. doi:10.1146/annurev. med.57.121304.131306. (Pubitemid 43261975)
25. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998;39(6):1016-20. (Pubitemid 28270118)
26. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994;264(5158):569-71.
27. Mousa SA. alphav Vitronectin receptors in vascular-mediated disorders. Med Res Rev 2003;23(2):190-9. doi:10.1002/med.10031. (Pubitemid 36241097)
28. Antonov AS, Antonova GN, Munn DH, Mivechi N, Lucas R, Catravas JD, et al. alphaVbeta3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-kappaB activation. J Cell Physiol 2011;226(2):469-76. doi:10.1002/jcp. 22356.